Related Experiment Videos
Alterations and Polymorphisms of the Estrogen Receptor Gene in Breast Cancer
1Department of Surgery II, Nagoya City University Medical School, 1 Kawasumi, Mizuho-ku, Nagoya 467, Japan.
Abstract:
The existence of hormone-independent tumors is a substantial problem for the present endocrine treatment of breast cancers. Recently, numerous variant estrogen receptors (ERs) at the mRNA level have been detected with base pair insertions, transitions, and deletions, as well as alternative splicing, yielding deletion of exon 3, 5, or 7. It has been shown that the loss of hormone dependence in breast tumors is partly due to the presence of mutated or truncated ERs that can activate the transcription of an estrogen-regulatable gene in the absence of estrogen. The mechanism of the loss of hormone dependency is, however, still very complex. Thus, further work assessing the correlation between clinical behavior and ER variants is required to determine whether these variants play a role in hormone-resistant disease. Additionally, a possible linkage to the ER gene has been found in some breast cancer families, suggesting that either the ER gene itself or an adjacent gene may be breast cancer susceptibility genes.
Insights
Variant estrogen receptors (ERs) may cause hormone-independent breast cancer, leading to treatment resistance. Further research is needed to understand ER variants
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hormone-independent tumors pose a significant challenge to current breast cancer endocrine therapy.
- Variant estrogen receptors (ERs) at the mRNA level, resulting from mutations or alternative splicing, have been identified.
Purpose of the Study:
- To investigate the role of estrogen receptor variants in the development of hormone-independent breast cancer.
- To assess the correlation between ER variants and clinical behavior in breast cancer patients.
Main Methods:
- Detection and characterization of various estrogen receptor (ER) variants at the mRNA level.
- Analysis of alternative splicing events leading to ER variants (e.g., exon deletions).
Main Results:
- Mutated or truncated ERs can activate gene transcription independently of estrogen, contributing to hormone resistance.
- Specific ER variants, such as those lacking exon 3, 5, or 7, are associated with altered receptor function.
Conclusions:
- Estrogen receptor variants are implicated in the loss of hormone dependence in breast tumors.
- Further investigation into ER variants is crucial for understanding and potentially overcoming endocrine resistance in breast cancer.
- A potential linkage between the ER gene and breast cancer susceptibility genes warrants further exploration.